Perceiv AI: TheraVac Biologics Partners With Perceiv AI to Optimize Clinical Trials Using Advanced AI and Prognostic Biomarkers
SAN FRANCISCO, CALIFORNIA / ACCESSWIRE / January 13, 2025 / TheraVac Biologics (TheraVac), a company developing innovative immunotherapies for neurological and autoimmune disease, is thrilled to an...
Read full article »
Perceiv AI is a Canada-based AI-driven precision medicine company that develops a prognostic platform to forecast disease progression in age-related disorders.
Read more